martes, 16 de abril de 2019

Final Recommendation Statement: Elevated Blood Lead Levels in Children and Pregnant Women: Screening - US Preventive Services Task Force

Final Recommendation Statement: Elevated Blood Lead Levels in Children and Pregnant Women: Screening - US Preventive Services Task Force



u s preventive services task force

Final Recommendation Statement:

Screening for Lead

Final Recommendation Statement: Screening for Elevated Blood Lead Levels in Children and Pregnant Women

The U.S. Preventive Services Task Force released today a final recommendation statement on screening for elevated blood lead levels in children and pregnant women. The Task Force’s final recommendation calls for more research on how clinicians can help prevent health problems related to lead exposure. To view the recommendation and the evidence on which it is based, please go here. The final recommendation statement can also be found in the April 16, 2019 online issue of JAMA.
The Final Recommendation Statement Is Available
read the final recommendation

FINAL RECOMMENDATION SUMMARY

Population
Recommendation
Grade
Children 5 years and younger
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for elevated blood lead levels in asymptomatic children.
I
Pregnant persons
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for elevated blood lead levels in asymptomatic pregnant persons.
I

WHY THIS MATTERS

Michael Silverstein
"We are calling for more research so clinicians can have better ways to prevent and treat health problems that can result from lead exposure,” says Task Force member Michael Silverstein, M.D., M.P.H. “Clinicians should use their best judgement about if and when to screen children and pregnant women without signs or symptoms for lead and keep up to date on any concerns about lead in their community.”

WHERE WE ARE IN THE PROCESS

Draft
Research Plan
Final
Research Plan
Draft
Recommendation / Draft Evidence Review 
Final Recommendation / Evidence Summary

No hay comentarios: